Showing results (1031-1040 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|October 23, 2026
EpiDirect enables rapid bisulfite-free MGMT promoter methylation testing in IDH-wildtype glioblastoma with high agreement across established assaysAttila Németh, Carmen Selignow, Annika May, et al.
Neuro-Oncology Advances|October 29, 2026
Sex differences in glycine biosynthesis drives sex-specific responses to combined nutrient deprivation and pharmacological inhibition in brain tumorsCamryn Marquez, Jianyun Lu, Kevin Cho, et al.
Neuro-Oncology Advances|October 28, 2026
Improved efficacy of orelabrutinib plus rituximab, temozolomide and high-dose methotrexate versus rituximab, high-dose methotrexate plus temozolomide in untreated primary CNS lymphoma: A matched analysisPeng Zhang, Man Nie, Hang Yang, et al.
Neuro-Oncology Advances|December 3, 2021
Laser interstitial thermal therapy for brain metastasesEthan S Srinivasan, Matthew M Grabowski, Brian V Nahed, et al.
Neuro-Oncology Advances|December 3, 2021
Advances in the management of breast cancer brain metastasesSarah Sammons, Amanda E D Van Swearingen, Caroline Chung, et al.
Neuro-Oncology Advances|December 3, 2021
A review of neurotoxicities associated with immunotherapy and a framework for evaluationLeeann B Burton, Mahsa Eskian, Amanda C Guidon, et al.
Neuro-Oncology Advances|February 3, 2021
Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expressionKevin B Givechian, Chad Garner, Steve Benz, et al.
Neuro-Oncology Advances|January 28, 2021
An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation statusManmeet Ahluwalia, Mir A Ali, Rushikesh S Joshi, et al.
Neuro-Oncology Advances|January 28, 2021
Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare studyDebra A Goldman, Anne S Reiner, Eli L Diamond, et al.
Neuro-Oncology Advances|January 28, 2021
A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesisEric A Horne, Philippe Diaz, Patrick J Cimino, et al.
Pageof 138